InflaRx
IFRX
18 hedge funds and large institutions have $212M invested in InflaRx in 2017 Q4 according to their latest regulatory filings, with 18 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
43.33% more ownership
Funds ownership: 0% → 43.33% (+43%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$51.9M |
| 2 |
BlackRock
New York
|
+$26.8M |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$26M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
+$15.5M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$10M |
Top Sellers
IFRX Hedge Fund Activity: Q4 2017 in Review
18 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in InflaRx (IFRX) for Q4 2017, worth a combined $212M.
Buyers outnumbered sellers: 18 funds opened new IFRX positions and 0 closed out — a net gain of 18 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was RA Capital Management, opening a new position worth an estimated $51.9M.
- 18 institutional investors held InflaRx (IFRX) as of Q4 2017, up from 0 in Q3 2017.
- Funds reported $212M of InflaRx stock for Q4 2017.
- 18 funds opened new InflaRx positions in Q4 2017 and 0 closed out, a net change of +18 holders.
- The largest InflaRx buyer in Q4 2017 was RA Capital Management, an estimated $51.9M added.
Based on aggregated 13F filings for Q4 2017.